Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 49

1.

Antithrombotic therapy for secondary stroke prevention.

Alberts MJ.

Continuum (Minneap Minn). 2011 Dec;17(6 2ndary Stroke Prevention):1255-66. doi: 10.1212/01.CON.0000410034.19230.03.

PMID:
22810029
[PubMed]
2.

Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.

Jamieson DG, Parekh A, Ezekowitz MD.

J Cardiovasc Pharmacol Ther. 2005 Sep;10(3):153-61. Review.

PMID:
16211203
[PubMed - indexed for MEDLINE]
3.

Role of emerging antithrombotic therapy in the prevention of cardioembolic complications in patients with atrial fibrillation.

Deedwania PC, Huang GW.

Am J Cardiovasc Drugs. 2011 Aug 1;11(4):265-75. doi: 10.2165/11592410-000000000-00000. Review.

PMID:
21740079
[PubMed - indexed for MEDLINE]
4.

New and emerging anticoagulant therapy for atrial fibrillation and acute coronary syndrome.

Davis EM, Packard KA, Knezevich JT, Campbell JA.

Pharmacotherapy. 2011 Oct;31(10):975-1016. doi: 10.1592/phco.31.10.975. Review.

PMID:
21950643
[PubMed - indexed for MEDLINE]
5.

New oral anticoagulants for atrial fibrillation: a review of clinical trials.

O'Dell KM, Igawa D, Hsin J.

Clin Ther. 2012 Apr;34(4):894-901. doi: 10.1016/j.clinthera.2012.01.019. Epub 2012 Mar 13. Review.

PMID:
22417716
[PubMed - indexed for MEDLINE]
6.

Adverse effects and drug interactions of antithrombotic agents used in prevention of ischaemic stroke.

Weinberger J.

Drugs. 2005;65(4):461-71. Review.

PMID:
15733010
[PubMed - indexed for MEDLINE]
7.

Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.

Jones L, Griffin S, Palmer S, Main C, Orton V, Sculpher M, Sudlow C, Henderson R, Hawkins N, Riemsma R.

Health Technol Assess. 2004 Oct;8(38):iii-iv, 1-196. Review.

PMID:
15461876
[PubMed - indexed for MEDLINE]
Free Article
8.

Prevention of stroke in patients with atrial fibrillation.

Olsson SB, Halperin JL.

Semin Vasc Med. 2005 Aug;5(3):285-92. Review.

PMID:
16123916
[PubMed - indexed for MEDLINE]
9.

Pharmacotherapy for the secondary prevention of stroke.

Toyoda K.

Drugs. 2009;69(6):633-47. doi: 10.2165/00003495-200969060-00001. Review.

PMID:
19405547
[PubMed - indexed for MEDLINE]
10.

Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.

Hankey GJ.

Curr Med Res Opin. 2007 Jun;23(6):1453-62. Epub 2007 May 17. Review.

PMID:
17559741
[PubMed - indexed for MEDLINE]
11.

New frontiers for stroke prevention in atrial fibrillation.

Prasad V, Kaplan RM, Passman RS.

Cerebrovasc Dis. 2012;33(3):199-208. doi: 10.1159/000334979. Epub 2012 Jan 19. Review.

PMID:
22261539
[PubMed - indexed for MEDLINE]
Free Article
12.

Combination antiplatelet agents for secondary prevention of ischemic stroke.

Vande Griend JP, Saseen JJ.

Pharmacotherapy. 2008 Oct;28(10):1233-42. doi: 10.1592/phco.28.10.1233. Review.

PMID:
18823219
[PubMed - indexed for MEDLINE]
13.

Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events.

Hankey GJ, Eikelboom JW.

Lancet Neurol. 2010 Mar;9(3):273-84. doi: 10.1016/S1474-4422(10)70038-7. Review.

PMID:
20170841
[PubMed - indexed for MEDLINE]
14.

Current guidelines on antiplatelet agents for secondary prevention of noncardiogenic stroke: an evidence-based review.

Simmons BB, Yeo A, Fung K; American Heart Association; American Stroke Association.

Postgrad Med. 2010 Mar;122(2):49-53. doi: 10.3810/pgm.2010.03.2121. Review.

PMID:
20203455
[PubMed - indexed for MEDLINE]
15.

Evaluation and management of atrial fibrillation.

Ali S, Hong M, Antezano ES, Mangat I.

Cardiovasc Hematol Disord Drug Targets. 2006 Dec;6(4):233-44. Review.

PMID:
17378769
[PubMed - indexed for MEDLINE]
16.

Guidelines for stroke prevention in patients with atrial fibrillation.

Howard PA.

Drugs. 1999 Dec;58(6):997-1009. Review.

PMID:
10651387
[PubMed - indexed for MEDLINE]
17.

Old and new anticoagulant agents for the prevention and treatment of patients with ischemic stroke.

MartĂ­-FĂ bregas J, Mateo J.

Cerebrovasc Dis. 2009;27 Suppl 1:111-9. doi: 10.1159/000200448. Epub 2009 Apr 3. Review.

PMID:
19342840
[PubMed - indexed for MEDLINE]
18.

New insights in antiplatelet therapy for patients with ischemic stroke.

Chaturvedi S, Bhattacharya P.

Neurologist. 2011 Sep;17(5):255-62. doi: 10.1097/NRL.0b013e318224ed70. Review.

PMID:
21881467
[PubMed - indexed for MEDLINE]
19.

New options for stroke prevention in atrial fibrillation.

Cannon CP, Stecker EC.

Am J Manag Care. 2010 Nov;16(10 Suppl):S291-7. Review.

PMID:
21517644
[PubMed - indexed for MEDLINE]
Free Article
20.

Will direct thrombin inhibitors replace warfarin for preventing embolic events in atrial fibrillation?

Reiffel JA.

Curr Opin Cardiol. 2004 Jan;19(1):58-63. Review.

PMID:
14688636
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk